Human trial success signals next stage of malaria vaccine developmentFeatures
Initial success in human clinical trials has given hope for the next stage in the development of a new malaria vaccine.
$1.2 million in funding for Griffith disease researchFeatures
Griffith University research into fighting diseases of global impact are set to benefit from the latest National Health and Medical Research Council (NHMRC) 2018 Fellowship Program funding outcomes. Principal Research Leader Professor Suresh Mahalingam of the Institute for Glycomics has been successful in obtaining a Senior Research Fellowship B (SRFB) for the project “Arbovirus-Induced Inflammatory Disease: […]
Outstanding Griffith research excellence honouredArchitecture
Leading Griffith University researchers have been honoured at the Vice Chancellor’s Research Excellence Awards held at Nathan campus.
The Liberal National Government has announced they will donate $500,000 to Griffith University’s Institute for Glycomics to support their ongoing human clinical trials which aim to test the effectiveness of a world-first malaria vaccine candidate named PlasProtecT™. Malaria is caused by an infection with malaria parasites, and is generally characterised by fever, shivering headaches and […]
Institute becomes member of Association of Australian Medical Research Institutes.
Academic offers insights into mosquito-borne diseases for live Q&A symposium.
The Governor-General, His Excellency General the Honourable Sir Peter Cosgrove AK MC (Retd), got first-hand insights into the world’s first human clinical trials of a whole parasite blood-stage malaria vaccine when he visited the Institute for Glycomics. In what was one of his last duties before retiring in March, General Cosgrove was given a tour and updates on the […]
Public health problem takes on 'superbug' status
Drug originally proposed to treat Alzheimer’s disease has potential to combat dangerous antibiotic-resistant bacteria.
A Griffith researcher has shared in a $5 million grant to develop ground-breaking research on stroke prevention. The Heart Foundation announced Professor Michael Good, from Griffith’s Institute for Glycomics, as one of the two Australian researchers who will share in the one-off grant open to researchers who could demonstrate they were working on innovative, internationally […]
Potential to improve early detection of disease possible with new test.
How highly pathogenic influenza viruses such as deadly bird flu infect humans is being unravelled.
New type of antibiotic could limit multidrug resistance by targeting and disrupting key elements in bacterial cells.
It’s a night for support and appreciation of the ground-breaking work being carried out by Griffith University’s Institute for Glycomics and everyone is invited to be part of this special occasion. The Institute’s Grand Ball Night is regarded as a show-stopper each year with the 2018 edition promising to deliver a memorable evening full of […]
Institute for Glycomics receives Federal Government grant to partner with China to create world-first drug to treat Hand, Foot and Mouth Disease (HFMD).
From paediatric palliative care and humanitarian dental work to a passion for astrophysics and groundbreaking scientific research into Malaria, the 2018 Alumni Awards showcase the rich diversity of Griffith’s Health and Science alumni.
Griffith University has become a collaborating partner with the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP), which will host a CNBP research node at the Institute for Glycomics at the Gold Coast campus.
Architecture, construction and planning
Some of Griffith University’s biggest names in science will trade the lab for the pub when fun and informative evening sessions kick off at pubs around the country in May. From May 14-16, the Pint Of Science festival will give Gold Coasters the opportunity to sit at the cutting edge of science with a beer […]